CIK 0001858848
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tenaya Therapeutics, Inc.
Sign in to watch- Ticker
- TNYA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813789973
- Phone
- +1 415-865-2066
- Business address
- 171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-11 | COLUMN GROUP III GP, LP 10% owner | Sale | −1,905,115 | $0.68 | $1.3M | 2,348,183 |
| 2026-02-11 | COLUMN GROUP III GP, LP 10% owner | Sale | −2,151,458 | $0.68 | $1.5M | 2,651,817 |
| 2026-02-10 | COLUMN GROUP III GP, LP 10% owner | Sale | −161,422 | $0.82 | $132K | 4,253,298 |
| 2026-02-10 | COLUMN GROUP III GP, LP 10% owner | Sale | −182,295 | $0.82 | $149K | 4,803,275 |
| 2026-02-03 | Higa Tomohiro SVP, Finance | Grant or award | +29,250 | 123,221 | ||
| 2026-02-03 | Higa Tomohiro SVP, Finance | Grant or award · Stock Option (Right to buy) | +175,500 | 175,500 | ||
| 2026-02-03 | Tingley Whittemore Chief Medical Officer | Grant or award | +48,750 | 223,778 | ||
| 2026-02-03 | Tingley Whittemore Chief Medical Officer | Grant or award · Stock Option (Right to buy) | +318,500 | 318,500 | ||
| 2026-02-03 | Ali Faraz Chief Executive Officer | Grant or award | +158,600 | 458,266 | ||
| 2026-02-03 | Ali Faraz Chief Executive Officer | Grant or award · Stock Option (Right to buy) | +952,250 | 952,250 | ||
| 2025-11-17 | Higa Tomohiro SVP, Finance | Sale | −1,367 | $1.33 | $2K | 93,971 |
| 2025-11-17 | Tingley Whittemore Chief Medical Officer | Sale | −2,877 | $1.33 | $4K | 169,926 |
| 2025-11-17 | Ali Faraz Chief Executive Officer | Sale | −3,126 | $1.33 | $4K | 299,666 |
| 2025-08-18 | Tingley Whittemore Chief Medical Officer | Sale | −1,608 | $1.25 | $2K | 176,248 |
| 2025-08-18 | Tingley Whittemore Chief Medical Officer | Sale | −1,608 | $1.25 | $2K | 174,640 |
| 2025-08-18 | Tingley Whittemore Chief Medical Officer | Sale | −1,837 | $1.25 | $2K | 172,803 |
| 2025-08-18 | Ali Faraz Chief Executive Officer | Sale | −5,720 | $1.25 | $7K | 311,605 |
| 2025-08-18 | Ali Faraz Chief Executive Officer | Sale | −3,893 | $1.25 | $5K | 307,712 |
| 2025-08-18 | Ali Faraz Chief Executive Officer | Sale | −4,920 | $1.25 | $6K | 302,792 |
| 2025-08-18 | Higa Tomohiro SVP, Finance | Sale | −523 | $1.25 | $655 | 97,777 |
Page 3 of 12 · 228 trades